Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians

Bacterial resistance mechanisms are continuously and rapidly evolving. This is particularly true for Gram-negative bacteria. Over the last decade, the strategy to develop new β-lactam/β-lactamase inhibitors (BLs/BLIs) combinations has paid off and results from phase 3 and real-world studies are beco...

Descripción completa

Detalles Bibliográficos
Autores principales: Principe, Luigi, Lupia, Tommaso, Andriani, Lilia, Campanile, Floriana, Carcione, Davide, Corcione, Silvia, De Rosa, Francesco Giuseppe, Luzzati, Roberto, Stroffolini, Giacomo, Steyde, Marina, Decorti, Giuliana, Di Bella, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028825/
https://www.ncbi.nlm.nih.gov/pubmed/35455461
http://dx.doi.org/10.3390/ph15040463

Ejemplares similares

Ejemplares similares